Cargill, BASF Plant Science to develop EPA/DHA canola oil

Cargill and BASF Plant Science have announced an agreement to co-develop a new dietary source of eicosapentaenoic and docosahexaenoic acid acids (EPA/DHA) that will make it easier for consumers to achieve optimal intakes of EPA- and DHArich omega-3 polyunsaturated fatty acids. The resultant canola oil containing EPA/DHA will enable food, pharmaceutical and nutritional supplement manufacturers to deliver the potential health benefi ts of omega-3 fatty acids in new, cost-effective products by the end of the decade.

Although research is ongoing, a growing body of scientifi c evidence links dietary intake of omega-3 fatty acids with benefi ts for heart and brain health. However, humans on average are currently not consuming enough of these healthy fatty acids. According to the National Health and Nutrition Examination Survey, EPA/DHA consumption in the US is less than 185 mg per day. Health experts in various countries recommend intake of 250-500 mg per day for positive health benefi ts from EPA/DHA.

Growing consumer awareness of the health benefi ts of omega-3 is fueling double-digit growth for omega-3 products. According to a recent report by Prepared Foods, the global market for food, beverages and supplements incorporating omega-3s was worth nearly $7.5 billion in 2010, and is predicted to grow 15-20% annually through 2015.

The project will leverage on Cargill’s food applications capabilities and existing commercial relationships with food manufacturers and food service operators globally, as well as BASF Plant Science’s expertise in genetically enhancing EPA/DHA levels in canola seed oil and deregulating it for use in food products.BASF Plant Science foresees a total investment of more than €150 million ($208 million). The products generated through the collaboration will address shelf stability and cost, which are the two issues affecting companies seeking to broadly deliver omega-3s to global consumers.